Quick Answer
Exousia Bio, Inc. reported Stockholders Equity of $0.00 for the year ending 2025.
- Exousia Bio, Inc. showed an increase of +100.0% in Stockholders Equity from 2024 to 2025.
- This data is from Exousia Bio, Inc.'s annual report (Form 10-K), filed with the SEC on October 17, 2025.
- XBRL data for this metric is available from 2022 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2022: -$13.4 thousand | Q4 2022: -$21.8 thousand | Q1 2023: -$27.1 thousand | Q3 2023: -$41.2 thousand | Q4 2023: -$44.8 thousand | Q1 2024: -$49.6 thousand | Q2 2024: -$54.9 thousand | Q3 2024: -$58.8 thousand | Q4 2024: $24.9 thousand | Q1 2025: $0.00 | Q2 2025: $0.00 | Q3 2025: -$35.3 thousand | Q4 2025: $21.79 million.
- Historical annual values: Fiscal year 2025: $0.00 | Fiscal year 2024: -$54.9 thousand | Fiscal year 2023: -$29.1 thousand | Fiscal year 2022: -$437.00 | Fiscal year 2022: $0.00.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: